---
title: "Biomarkers of ASD"
subtitle: "If you want a subtitle put it here"
author: "Lucas Childs,..."
date: last-modified
published-title: "Updated"
editor: visual
format: html
code-copy: true
execute:
  message: false
  warning: false
  echo: false
  cache: true
---

Use this as a template. Keep the headers and remove all other text. In all, your report can be quite short. When it is complete, render and then push changes to your team repository.

```{r}
# load any other packages and read data here
library(tidyverse)
```

## Abstract

Write a brief one-paragraph abstract that describes the contents of your write-up.

This report covers an analysis of blood biomarkers for autism spectrum disorder (ASD), analyzing proteins and their association with ASD. Emulating the paper Hewitson et al. 2021, we analyze the dataset used in the paper, data preprocessing including transformations and outlier trimmings, methodologies for selecting a panel of proteins for ASD classification, and improvement in protein panel selection.

## Dataset

Write a brief data description, including: how data were obtained; sample characteristics; variables measured; and data preprocessing. This can be largely based on the source paper and should not exceed 1-2 paragraphs.

Data was taken via blood serum sample from 76 boys with ASD and 78 typically developing (TD) boys ranging from 18 months - 8 years of age. The serum samples were analyzed to identify possible eraly biological markers for ASD. Proteomic analysis of serum was performed using SomaLogicâ€™s SOMAScan$^{TM}$ assay 1.3K platform. A total of 1,317 proteins were analyzed, with two additional variables `ADOS` and `group` pertaining to ASD severity and whether the subject is TD or has ASD. Data preprocessing was done to eliminate missing values, $log_{10}$ transform biomarker levels to stabilize variance, large values, and normalize skewed distributions, center and scale transformed data to standardize the distribution of each biomarker, and trim outliers to prevent disproportionate influence.

## Summary of published analysis

Summarize the methodology of the paper in 1-3 paragraphs. You need not explain the methods in depth as we did in class; just indicate what methods were used and how they were combined. If possible, include a diagram that depicts the methodological design. (Quarto has support for [GraphViz and Mermaid flowcharts](https://quarto.org/docs/authoring/diagrams.html).) Provide key results: the proteins selected for the classifier and the estimated accuracy.

**Q1:** A logarithmic transformation was done to the biomarker levels in order to reduce scale, variance, and skewedness of the data. Furthermore, the data was centered and scaled to standardize the distribution of each biomarker.

**Q4:** We chose to find an alternate protein panel that achieves improved classification accuracy using a guided LASSO approach with differential penalties. Proteins identified through both multiple testing with t-tests and Random Forest importance (`proteins_sstar`) were assigned zero penalty to ensure these were included in the panel without significant shrinkage due to regularization. So, this prior validation was used since there was strong prior evidence that these proteins were relevant. The remaining proteins not selected by the two aforementioned methods received L1 regularization (LASSO regularization), allowing us to discover additional predictive biomarkers while controlling overfitting. We can think of this method from a Bayesian standpoint where the prior data (pre-selected panel of 5 proteins, `proteins_sstar`) informed our belief about protein importance. Overall, our method displayed increased classification accuracy, specifically highlighted by the metric: 'accuracy'. The metrics are depicted below:

$$
\begin{array}{llr}
\hline
\textbf{metric} & \textbf{estimator} & \textbf{estimate} \\
\hline
\text{sensitivity} & \text{binary} & 0.750 \\
\text{specificity} & \text{binary} & 0.933 \\
\text{accuracy} & \text{binary} & 0.839 \\
\text{roc auc} & \text{binary} & 0.858 \\
\hline
\end{array}
$$ Compared to the benchmark results: $$
\begin{array}{llr}
\hline
\textbf{metric} & \textbf{estimator} & \textbf{estimate} \\
\hline
\text{sensitivity} & \text{binary} & 0.812 \\
\text{specificity} & \text{binary} & 0.733 \\
\text{accuracy} & \text{binary} & 0.774 \\
\text{roc auc} & \text{binary} & 0.883 \\
\hline
\end{array}
$$

The proteins selected for the classifier are the following:

-   CD59
-   4-1BB
-   Dtk
-   Cadherin-5
-   HAI-1
-   Kallikrein 11
-   PAI-1
-   Growth hormone receptor
-   IGFBP-4
-   MRC2
-   CRDL1
-   IL-17 RD
-   TPSG1
-   MP2K2
-   ENPP7
-   MFGM
-   PCSK7
-   ITI heavy chain H4
-   IgD
-   DBNL
-   DERM
-   Elafin
-   RELT
-   PPID
-   Semaphorin 3E
-   CD27
-   CNDP1
-   IL-17 RC
-   SRCN1
-   Epo
-   GDNF
-   14-3-3 protein zeta/delta
-   a-Synuclein
-   CSRP3
-   MIG

## Findings

Summarize your findings here. I've included some subheaders in a way that seems natural to me; you can structure this section however you like.

### Impact of preprocessing and outliers

**Task 1:** After looking at the raw protein level distributions for a sample of 4 proteins in the dataset, it became clear that the scale of each protein level was very different across proteins. For example, one protein's mean was 17,164 while another's was 458. Furthermore, we found certain proteins had skewed distributions where one protein had a mean roughly 5,000 units larger than its median, indicating a right skew. Looking at each protein's density further revealed the differing scales of each protein level, large outliers, and skewed distributions apparent in 2 out of the 4 randomly selected proteins.

The log transformation of the protein levels helps to compress the scale of protein levels across the wide range of positive values that were encountered. Additionally, the logarithm helps with skewed data, helping to make data more symmetric and closer to a normal distribution (as confirmed with histograms and a QQ Plot).

**Task 2:**

### Methodological variations

Task 3

### Improved classifier

**Task 4:** Our alternate protein panel consisted of 35 proteins versus the 5 used in the `inclass-analysis`. We found that combining prior knowledge of protein importance with regularized classification lead to the best model accuracy. Overall our method of combining multiple t-tests, Random Forest importance, and the guided LASSO approach led to improved results compared to the baseline displaying $8\%$ increase in accuracy, $27\%$ increase in specificity, $\approx 3\%$ decrease in AUC, and an $8\%$ decrease in sensitivity. Even though AUC and sensitivity decreased slightly, the other metrics show an overall improvement in classification accuracy.

We also found that just running LASSO regularization on the whole set of proteins led to similar but slightly decreased classification accuracy compared to the baseline approach. In order to navigate around this, the incorporated prior knowledge of the 2-method statistically validated panel of proteins proved useful.
